Singapore markets closed

  • Straits Times Index

    3,217.41
    +10.42 (+0.32%)
     

  • Nikkei

    31,857.62
    -14.90 (-0.05%)
     

  • Hang Seng

    17,809.66
    +436.63 (+2.51%)
     

  • FTSE 100

    7,608.08
    +6.23 (+0.08%)
     

  • Bitcoin USD

    27,168.93
    +212.53 (+0.79%)
     

  • CMC Crypto 200

    579.66
    +0.90 (+0.15%)
     

  • S&P 500

    4,288.05
    -11.65 (-0.27%)
     

  • Dow

    33,507.50
    -158.84 (-0.47%)
     

  • Nasdaq

    13,219.32
    +18.05 (+0.14%)
     

  • Gold

    1,864.60
    -14.00 (-0.75%)
     

  • Crude Oil

    90.77
    -0.94 (-1.02%)
     

  • 10-Yr Bond

    4.5730
    -0.0240 (-0.52%)
     

  • FTSE Bursa Malaysia

    1,424.17
    -15.94 (-1.11%)
     

  • Jakarta Composite Index

    6,939.89
    +2.06 (+0.03%)
     

  • PSE Index

    6,321.24
    -64.28 (-1.01%)
     

Why Shares of BioCryst Pharmaceuticals Jumped Today

Jim Halley, The Motley Fool
·2-min read
Why Shares of BioCryst Pharmaceuticals Jumped Today

Shares of BioCryst Pharmaceuticals (NASDAQ: BCRX) were up 12% Wednesday afternoon, a day after the commercial-stage biotech released full-year and fourth-quarter earnings. The stock dropped as much as 17.1% on Tuesday after the earnings report, but Wednesday, it bounced back as much as 14% over the day before. Needham upgraded the stock to "buy" from "hold," adding a $14 price target, and H.C. Wainwright analyst Andrew Fein set a price target of $30 on the stock and reiterated his buy rating.

Continue reading